{"id":"W4392235779","doi":"10.3389/fphar.2024.1302015","title":"Evaluating the effectiveness of a novel somatostatin receptor 2 antagonist, ZT-01, for hypoglycemia prevention in a rodent model of type 2 diabetes","year":2024,"lang":"en","type":"article","venue":"Frontiers in Pharmacology","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"York University","funders":"Canadian Glycomics Network; Mitacs; Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada; Breakthrough T1D Canada; Natural Sciences and Engineering Research Council of Canada; Government of Canada","keywords":"Somatostatin; Hypoglycemia; Somatostatin receptor; Type 2 diabetes; Medicine; Antagonist; Rodent model; Pharmacology; Rodent; Diabetes mellitus; Endocrinology; Internal medicine; Receptor; Biology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029384,0.0007463995,0.0007385338,0.000333687,0.0002218655,0.0003727711,0.0005367476,0.0005735073,0.001510122],"category_scores_gemma":[0.0001675118,0.0002724901,0.0005260587,0.000237235,0.0003561574,0.0004574509,0.0001372414,0.001668452,0.0003440928],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003647997,"about_ca_system_score_gemma":0.000550635,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007124161,"about_ca_topic_score_gemma":0.001856393,"domain_scores_codex":[0.9998482,0.00002080065,0.0000173213,0.00003082912,0.00003324473,0.00004954169],"domain_scores_gemma":[0.9997668,0.00001980473,0.00007816321,0.00001712117,0.0000253324,0.00009268498],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.008467742,0.002945362,0.0007020229,0.0002453189,0.00005668391,0.00009906225,0.00002984953,0.0002674058,0.9788239,0.0001191425,0.00024346,0.00799997],"study_design_scores_gemma":[0.003156082,0.1023443,0.009674331,0.00006027956,0.000372875,0.000534987,0.0001469515,0.001819453,0.8784755,0.00009330397,0.00328521,0.00003651621],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960244,0.001461522,0.0009266466,0.0001560378,0.00007727502,0.0001094687,0.0004707589,0.00005753698,0.0007163035],"genre_scores_gemma":[0.988221,0.003402896,0.004166775,0.0002271879,0.00006653521,0.0003655477,0.00135332,0.00002816303,0.002168572],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001510122,"threshold_uncertainty_score":0.005051851,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04551783078415422,"score_gpt":0.3760425555796506,"score_spread":0.3305247247954963,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}